The Health Kick Podcast with Tim Boreham en Tim is Stockhead’s resident Health and Biotech expert with his weekly column “Dr Boreham’s Crucible”. Tim was the author of the Criterion column in The Australian newspaper for well over 10 years and has more than three decades’ experience of business reporting across three major publications. In his weekly “The Health Kick Podcast” Tim will interview Australia’s leading Health and Biotech industry leaders, bringing his own unique insight and perspective into the world of health and drug discovery. https://megaphone.imgix.net/podcasts/63e8fb1e-4821-11ed-b747-23bada251e3a/image/618998-health_kick_logo_3000x3000_final.png?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress The Health Kick Podcast with Tim Boreham no episodic Stockhead Tim is Stockhead’s resident Health and Biotech expert with his weekly column “Dr Boreham’s Crucible”. Tim was the author of the Criterion column in The Australian newspaper for well over 10 years and has more than three decades’ experience of business reporting across three major publications. In his weekly “The Health Kick Podcast” Tim will interview Australia’s leading Health and Biotech industry leaders, bringing his own unique insight and perspective into the world of health and drug discovery. Stockhead riley.duke@stockhead.com.au Health Kick Podcast: Health Food Symmetry In this episode Tim chats to Gordon Edwards, CEO of Health Food Symmetry Learn more about your ad choices. Visit megaphone.fm/adchoices Sun, 14 Dec 2025 19:00:00 -0000 full Stockhead In this episode Tim chats to Gordon Edwards, CEO of Health Food Symmetry Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats to Gordon Edwards, CEO of Health Food Symmetry

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1451 Health Kick Podcast: The Calmer Co (ASX:CCO) In this episode Tim chats to  Zane Yoshida, CEO and Founder of The Calmer Co (ASX:CCO) Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 03 Dec 2025 16:00:00 -0000 full Stockhead In this episode Tim chats to  Zane Yoshida, CEO and Founder of The Calmer Co (ASX:CCO) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats to  Zane Yoshida, CEO and Founder of The Calmer Co (ASX:CCO)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1432 Health Kick Podcast: Cynata Therapeutics (ASX:CYP) In this episode Tim chats to Dr. Kilian Kelly, CEO and Managing Director of Cynata Therapeutics (ASX:CYP) Learn more about your ad choices. Visit megaphone.fm/adchoices Mon, 01 Dec 2025 19:00:00 -0000 full Stockhead In this episode Tim chats to Dr. Kilian Kelly, CEO and Managing Director of Cynata Therapeutics (ASX:CYP) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats to Dr. Kilian Kelly, CEO and Managing Director of Cynata Therapeutics (ASX:CYP)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1520 Health Kick Podcast: Neurizon Therapeutics (ASX:NUZ) In this episode Tim chats to Dr Michael Thurn, Managing Director of Neurizon Therapeutics (ASX:NUZ) Learn more about your ad choices. Visit megaphone.fm/adchoices Sun, 31 Aug 2025 16:00:00 -0000 full Stockhead In this episode Tim chats to Dr Michael Thurn, Managing Director of Neurizon Therapeutics (ASX:NUZ) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats to Dr Michael Thurn, Managing Director of Neurizon Therapeutics (ASX:NUZ)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1597 Health Kick Podcast: Argenica Therapeutics (ASX:AGN) In this episode Tim chats to Liz Dallimore, Managing Director of Argenica Therapeutics (ASX:AGN) Learn more about your ad choices. Visit megaphone.fm/adchoices Mon, 18 Aug 2025 19:00:00 -0000 full Stockhead In this episode Tim chats to Liz Dallimore, Managing Director of Argenica Therapeutics (ASX:AGN) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats to Liz Dallimore, Managing Director of Argenica Therapeutics (ASX:AGN)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1466 Health Kick Podcast: Alterity Therapeutics (ASX:ATH) In this episode, Tim chats to David Stamler, Managing Director of Alterity Therapeutics (ASX:ATH) Learn more about your ad choices. Visit megaphone.fm/adchoices Sun, 10 Aug 2025 19:00:00 -0000 full Stockhead In this episode, Tim chats to David Stamler, Managing Director of Alterity Therapeutics (ASX:ATH) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode, Tim chats to David Stamler, Managing Director of Alterity Therapeutics (ASX:ATH)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1409 Health Kick Podcast: Imagion Biosystems (ASX:IBX) In this episode, Tim chats to Chairman Robert Proulx and Dr Leonardo Kayat Bittencourt of Imagion Biosystems (ASX:IBX) Learn more about your ad choices. Visit megaphone.fm/adchoices Sun, 03 Aug 2025 19:00:00 -0000 full Stockhead In this episode, Tim chats to Chairman Robert Proulx and Dr Leonardo Kayat Bittencourt of Imagion Biosystems (ASX:IBX) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode, Tim chats to Chairman Robert Proulx and Dr Leonardo Kayat Bittencourt of Imagion Biosystems (ASX:IBX)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1446 Health Kick Podcast: Neurizon Therapeutics (ASX:NUZ) In this episode Tim chats to Dr Michael Thurn, Managing Director of Neurizon Therapeutics (ASX:NUZ). Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 09 Jul 2025 16:00:00 -0000 full Stockhead In this episode Tim chats to Dr Michael Thurn, Managing Director of Neurizon Therapeutics (ASX:NUZ). Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats to Dr Michael Thurn, Managing Director of Neurizon Therapeutics (ASX:NUZ).

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1520 Health Kick Podcast: Filamon In this episode Tim chats to Professor Paul de Souza, Co-founder of Health Kick Podcast: Filamon Learn more about your ad choices. Visit megaphone.fm/adchoices Mon, 07 Jul 2025 23:52:00 -0000 full Stockhead In this episode Tim chats to Professor Paul de Souza, Co-founder of Health Kick Podcast: Filamon Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats to Professor Paul de Souza, Co-founder of Health Kick Podcast: Filamon

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1327 Health Kick Podcast: Aroa Biosurgery (ASX:ARX) In this episode Tim chats to James Agnew, CFO of Aroa Biosurgery (ASX:ARX). Learn more about your ad choices. Visit megaphone.fm/adchoices Thu, 05 Jun 2025 16:00:00 -0000 full Stockhead In this episode Tim chats to James Agnew, CFO of Aroa Biosurgery (ASX:ARX). Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats to James Agnew, CFO of Aroa Biosurgery (ASX:ARX).

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1614 Health Kick Podcast: Arovella Therapeutics (ASX:ALA) In this episode Tim chats to Dr. Michael Baker, CEO and Managing Director of Arovella Therapeutics (ASX:ALA) Learn more about your ad choices. Visit megaphone.fm/adchoices Thu, 10 Apr 2025 23:46:00 -0000 full Stockhead In this episode Tim chats to Dr. Michael Baker, CEO and Managing Director of Arovella Therapeutics (ASX:ALA) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats to Dr. Michael Baker, CEO and Managing Director of Arovella Therapeutics (ASX:ALA)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1297 Health Kick Podcast: AdAlta (ASX:1AD) In this episode Tim chats to Tim Oldham,CEO and Managing Director of AdAlta (ASX:1AD) Learn more about your ad choices. Visit megaphone.fm/adchoices Thu, 10 Apr 2025 00:26:00 -0000 full Stockhead In this episode Tim chats to Tim Oldham,CEO and Managing Director of AdAlta (ASX:1AD) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats to Tim Oldham,CEO and Managing Director of AdAlta (ASX:1AD)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1468 Health Kick Podcast: Imagion Biosystems (ASX:IBX) In this episode Tim chats to Robert Proulx, Chairman of Imagion Biosystems (ASX:IBX) Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 12 Mar 2025 19:00:00 -0000 full Stockhead In this episode Tim chats to Robert Proulx, Chairman of Imagion Biosystems (ASX:IBX) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats to Robert Proulx, Chairman of Imagion Biosystems (ASX:IBX)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1431 no Health Kick Podcast: Aroa Biosurgery (ASX:ARX) In this episode Tim chats to Dr Brian Ward, Founder and CEO of Aroa Biosurgery (ASX:ARX) Learn more about your ad choices. Visit megaphone.fm/adchoices Sun, 09 Feb 2025 19:00:00 -0000 full Stockhead In this episode Tim chats to Dr Brian Ward, Founder and CEO of Aroa Biosurgery (ASX:ARX) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats to Dr Brian Ward, Founder and CEO of Aroa Biosurgery (ASX:ARX)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1252 Health Kick Podcast: Neurizon Therapeutics (ASX:NUZ) In this episode Tim chats to Dr Michael Thurn, Managing Director of Neurizon Therapeutics (ASX:NUZ) Learn more about your ad choices. Visit megaphone.fm/adchoices Mon, 06 Jan 2025 16:00:00 -0000 full Stockhead In this episode Tim chats to Dr Michael Thurn, Managing Director of Neurizon Therapeutics (ASX:NUZ) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats to Dr Michael Thurn, Managing Director of Neurizon Therapeutics (ASX:NUZ)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1421 Health Kick Podcast: TrivarX (ASX:TRI) In this episode Tim chats to Kai Sun, Chief Operating Officer of TrivarX (ASX:TRI) Learn more about your ad choices. Visit megaphone.fm/adchoices Sun, 06 Oct 2024 19:00:00 -0000 full Stockhead In this episode Tim chats to Kai Sun, Chief Operating Officer of TrivarX (ASX:TRI) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats to Kai Sun, Chief Operating Officer of TrivarX (ASX:TRI)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1256 Health Kick Podcast: Recce Pharmaceuticals (ASX:RCE) In this episode Tim chats to James Graham, Managing director and CEO of Recce Pharmaceuticals (ASX:RCE) Learn more about your ad choices. Visit megaphone.fm/adchoices Thu, 26 Sep 2024 19:00:00 -0000 full Stockhead In this episode Tim chats to James Graham, Managing director and CEO of Recce Pharmaceuticals (ASX:RCE) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats to James Graham, Managing director and CEO of Recce Pharmaceuticals (ASX:RCE)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1277 Health Kick Podcast: Singular Health Group (ASX:SHG) In this episode Tim chats to Denning Chong, CEO and Director of Singular Health Group (ASX:SHG) Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 24 Sep 2024 19:00:00 -0000 full Stockhead In this episode Tim chats to Denning Chong, CEO and Director of Singular Health Group (ASX:SHG) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats to Denning Chong, CEO and Director of Singular Health Group (ASX:SHG)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1291 Health Kick Podcast: PharmAust (ASX:PAA) In this episode Tim chats to Dr Michael Thurn, Managing Director of PharmAust (ASX:PAA) Learn more about your ad choices. Visit megaphone.fm/adchoices Mon, 23 Sep 2024 23:35:00 -0000 full Stockhead In this episode Tim chats to Dr Michael Thurn, Managing Director of PharmAust (ASX:PAA) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats to Dr Michael Thurn, Managing Director of PharmAust (ASX:PAA)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1672 Health Kick Podcast: Aroa Biosurgery (ASX:ARX) In this episode Tim chats to Brian Ward, Founder and CEO of Aroa Biosurgery (ASX:ARX) Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 18 Sep 2024 23:38:00 -0000 full Stockhead In this episode Tim chats to Brian Ward, Founder and CEO of Aroa Biosurgery (ASX:ARX) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats to Brian Ward, Founder and CEO of Aroa Biosurgery (ASX:ARX)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1469 AdAlta is tackling Idiopathic Pulmonary Fibrosis with their next generation research and proprietary i-body technology In this episode Tim chats to Tim Oldham, CEO and Managing Director of AdAlta (ASX:1AD) Learn more about your ad choices. Visit megaphone.fm/adchoices Mon, 26 Aug 2024 19:00:00 -0000 full Stockhead In this episode Tim chats to Tim Oldham, CEO and Managing Director of AdAlta (ASX:1AD) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats to Tim Oldham, CEO and Managing Director of AdAlta (ASX:1AD)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1586 Prescient Therapeutics an emerging global leader in the next generation of personalised cancer therapies In this episode Tim chats to Steven Yatomi-Clarke, CEO of Prescient Therapeutics (ASX:PTX) Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 11 Jul 2023 00:33:38 -0000 full Stockhead In this episode Tim chats to Steven Yatomi-Clarke, CEO of Prescient Therapeutics (ASX:PTX) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats to Steven Yatomi-Clarke, CEO of Prescient Therapeutics (ASX:PTX)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1527 Aussie biotech Dimerix expects first data from their DMX200 phase 3 trial by end of year In this episode Tim chats to Nina Webster, CEO & Managing Director at Dimerix (ASX:DXB). Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 19 Apr 2023 01:32:46 -0000 full Stockhead In this episode Tim chats to Nina Webster, CEO & Managing Director at Dimerix (ASX:DXB). Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats to Nina Webster, CEO & Managing Director at Dimerix (ASX:DXB).

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1416 Prescient Therapeutics’ PTX-10 continues to show encouraging results following FDA Orphan Drug Designation  In this episode Tim chats to Steven Yatomi-Clarke, CEO of Prescient Therapeutics (ASX:PTX). Learn more about your ad choices. Visit megaphone.fm/adchoices Mon, 03 Apr 2023 04:40:00 -0000 full Stockhead In this episode Tim chats to Steven Yatomi-Clarke, CEO of Prescient Therapeutics (ASX:PTX). Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats to Steven Yatomi-Clarke, CEO of Prescient Therapeutics (ASX:PTX).

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1462 EZZ signs agreement with University of Auckland to conduct product research In this episode Tim chats to Glenn Cross, independent non-executive director and chairman at EZZ Life Science (ASX:EZZ) Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 29 Mar 2023 05:56:13 -0000 full Stockhead In this episode Tim chats to Glenn Cross, independent non-executive director and chairman at EZZ Life Science (ASX:EZZ) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats to Glenn Cross, independent non-executive director and chairman at EZZ Life Science (ASX:EZZ)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1269 Aussie Bio Tech Medlab is confident in highly anticipated Phase III trial In this episode Tim chats to Sean Hall, CEO at Medlab Clinical (ASX:MDC). Learn more about your ad choices. Visit megaphone.fm/adchoices Mon, 13 Feb 2023 23:48:56 -0000 full Stockhead In this episode Tim chats to Sean Hall, CEO at Medlab Clinical (ASX:MDC). Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats to Sean Hall, CEO at Medlab Clinical (ASX:MDC).

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1368 PTX partners with the US’s largest cancer centre to continue development of personalised cancer treatment In this episode Tim chats to Steven Yatomi-Clarke, CEO of Prescient Therapeutics (ASX:PTX). Learn more about your ad choices. Visit megaphone.fm/adchoices Thu, 08 Sep 2022 23:45:00 -0000 full 1 61 Stockhead In this episode Tim chats to Steven Yatomi-Clarke, CEO of Prescient Therapeutics (ASX:PTX). Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats to Steven Yatomi-Clarke, CEO of Prescient Therapeutics (ASX:PTX).

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1448 no NGS's growth just accelerated with launch into 403 select Walmart stores In this episode Tim sits down with Liron Fendell, CEO and Managing Director of Nutritional Growth Solutions (ASX:NGS) Learn more about your ad choices. Visit megaphone.fm/adchoices Thu, 25 Aug 2022 02:07:00 -0000 full 1 60 Stockhead In this episode Tim sits down with Liron Fendell, CEO and Managing Director of Nutritional Growth Solutions (ASX:NGS) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim sits down with Liron Fendell, CEO and Managing Director of Nutritional Growth Solutions (ASX:NGS)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1237 no Bionomic charges forward with lead drug candidate treatment for ptsd and social anxiety disorder In this episode Tim sits down with Dr Errol De Souza, Executive Chairman at Bionomics (ASX:BNO) Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 17 Aug 2022 06:11:00 -0000 full 1 59 Stockhead In this episode Tim sits down with Dr Errol De Souza, Executive Chairman at Bionomics (ASX:BNO) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim sits down with Dr Errol De Souza, Executive Chairman at Bionomics (ASX:BNO)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1534 no How Osteopore is innovating in the area of bone and tissue regeneration In this episode Tim chats to Mark Leong, non executive chairman at Osteopore (ASX:OSX) Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 10 Aug 2022 03:48:00 -0000 full 1 58 Stockhead In this episode Tim chats to Mark Leong, non executive chairman at Osteopore (ASX:OSX) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats to Mark Leong, non executive chairman at Osteopore (ASX:OSX)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1366 no Audeara’s revenue up nearly 140% YoY - up 50% from the previous quarter In this episode Tim chats to James Fielding co-founder and CEO of Audeara (ASX:AUA) Learn more about your ad choices. Visit megaphone.fm/adchoices Thu, 17 Feb 2022 05:57:00 -0000 full 1 57 Stockhead In this episode Tim chats to James Fielding co-founder and CEO of Audeara (ASX:AUA) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats to James Fielding co-founder and CEO of Audeara (ASX:AUA)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1160 no Life sciences expert David Williams on local medical innovations, tech leaders and sector opportunities Tim chats with David Williams, Managing Director of Kidder Williams Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 07 Dec 2021 07:19:00 -0000 full 1 56 Stockhead Tim chats with David Williams, Managing Director of Kidder Williams Learn more about your ad choices. Visit megaphone.fm/adchoices Tim chats with David Williams, Managing Director of Kidder Williams

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1840 no ASX biotech Dimerix gains momentum from involvement in multiple COVID-19 studies Tim chats with Nina Webster, CEO & Managing Director of Dimerix Ltd (ASX:DXB). Learn more about your ad choices. Visit megaphone.fm/adchoices Mon, 29 Nov 2021 23:53:00 -0000 full 1 55 Stockhead Tim chats with Nina Webster, CEO & Managing Director of Dimerix Ltd (ASX:DXB). Learn more about your ad choices. Visit megaphone.fm/adchoices Tim chats with Nina Webster, CEO & Managing Director of Dimerix Ltd (ASX:DXB).

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1310 no TALi Digital is using gamification to spot hard-to-identify cognitive function and attention deficit issues in children Tim chats Glenn Smith, Managing Director of Tali Digital (ASX:TD1) Learn more about your ad choices. Visit megaphone.fm/adchoices Fri, 03 Sep 2021 01:55:00 -0000 full 1 54 Stockhead Tim chats Glenn Smith, Managing Director of Tali Digital (ASX:TD1) Learn more about your ad choices. Visit megaphone.fm/adchoices Tim chats Glenn Smith, Managing Director of Tali Digital (ASX:TD1)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1602 Wellnex CEO George Karafotias discusses the company's wellness pivot, legacy product range and growth plans Tim chat's with George Karafotias, Group CEO of Wellnex Life Ltd (ASX:WNX) Learn more about your ad choices. Visit megaphone.fm/adchoices Thu, 26 Aug 2021 00:51:00 -0000 full 1 53 Stockhead Tim chat's with George Karafotias, Group CEO of Wellnex Life Ltd (ASX:WNX) Learn more about your ad choices. Visit megaphone.fm/adchoices Tim chat's with George Karafotias, Group CEO of Wellnex Life Ltd (ASX:WNX)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1435 no New ASX stock HitIQ has a revolutionary solution for the concussion problem in contact sport In this episode Tim chats to Mike Vegar, Co-Founder & Managing Director at HitIQ (ASX:HIQ) Learn more about your ad choices. Visit megaphone.fm/adchoices Thu, 19 Aug 2021 23:35:00 -0000 full 1 52 Stockhead In this episode Tim chats to Mike Vegar, Co-Founder & Managing Director at HitIQ (ASX:HIQ) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats to Mike Vegar, Co-Founder & Managing Director at HitIQ (ASX:HIQ)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1371 no Prescient Therapeutics' YTD share price soars +220% following CAR-T and clinical study progress In this episode Tim chats to Steven Yatomi-Clarke, CEO and Managing Director at Prescient Therapeutics (ASX:PTX) Learn more about your ad choices. Visit megaphone.fm/adchoices Thu, 19 Aug 2021 02:40:00 -0000 full 1 51 Stockhead In this episode Tim chats to Steven Yatomi-Clarke, CEO and Managing Director at Prescient Therapeutics (ASX:PTX) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats to Steven Yatomi-Clarke, CEO and Managing Director at Prescient Therapeutics (ASX:PTX)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1427 no New ASX listee Audeara uses algorithms to create perfect audio and better hearing health outcomes In this edition Tim talks to James Fielding, CEO at Audeara (ASX:AUA). Learn more about your ad choices. Visit megaphone.fm/adchoices Mon, 07 Jun 2021 02:45:00 -0000 full 1 50 Stockhead In this edition Tim talks to James Fielding, CEO at Audeara (ASX:AUA). Learn more about your ad choices. Visit megaphone.fm/adchoices In this edition Tim talks to James Fielding, CEO at Audeara (ASX:AUA).

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1335 no Widely used injectable contrast dyes have serious health impacts, Osprey Medical has a solution In this episode Tim chats to Mike McCormick, President & CEO of Osprey Medical (ASX:OSP) Learn more about your ad choices. Visit megaphone.fm/adchoices Mon, 24 May 2021 03:23:00 -0000 full 1 49 Stockhead In this episode Tim chats to Mike McCormick, President & CEO of Osprey Medical (ASX:OSP) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats to Mike McCormick, President & CEO of Osprey Medical (ASX:OSP)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1384 no New ASX player Control Bionics is commercialising tech that enables communication through neural signals In this episode Tim chats to Rob Wong, CEO of Control Bionics (ASX:CBL) Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 11 May 2021 00:10:00 -0000 full 1 48 Stockhead In this episode Tim chats to Rob Wong, CEO of Control Bionics (ASX:CBL) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats to Rob Wong, CEO of Control Bionics (ASX:CBL)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1398 no Kazia tackles the curse of US politicians with its innovative drug candidate In this episode Tim chats with James Garner, CEO at Kazia Therapeutics (ASX:KZA). Learn more about your ad choices. Visit megaphone.fm/adchoices Fri, 12 Mar 2021 00:27:00 -0000 full 1 47 Stockhead In this episode Tim chats with James Garner, CEO at Kazia Therapeutics (ASX:KZA). Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats with James Garner, CEO at Kazia Therapeutics (ASX:KZA).

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1433 no Entrepreneur Dr Chris Behrenbruch on taking Telix Pharma to a billion dollars, the future of nuclear medicine and more This week Tim chats to Chris Behrenbruch, Bioscience Entrepreneur and CEO of Telix Pharmaceuticals Limited (ASX:TLX). Learn more about your ad choices. Visit megaphone.fm/adchoices Mon, 08 Mar 2021 02:06:00 -0000 full 1 46 Stockhead This week Tim chats to Chris Behrenbruch, Bioscience Entrepreneur and CEO of Telix Pharmaceuticals Limited (ASX:TLX). Learn more about your ad choices. Visit megaphone.fm/adchoices This week Tim chats to Chris Behrenbruch, Bioscience Entrepreneur and CEO of Telix Pharmaceuticals Limited (ASX:TLX).

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1763 no Renowned biotech entrepreneur Paul Hopper on raising money, picking biotech winners and his latest ASX venture Tim chats with renowned Australian biotech entrepreneur Paul Hopper. Learn more about your ad choices. Visit megaphone.fm/adchoices Mon, 01 Mar 2021 01:39:00 -0000 full 1 45 Stockhead Tim chats with renowned Australian biotech entrepreneur Paul Hopper. Learn more about your ad choices. Visit megaphone.fm/adchoices Tim chats with renowned Australian biotech entrepreneur Paul Hopper.


Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1385 no NSB brings new solutions to a handful medicine's most stubborn eye problems This week Tim chats with Brian Leedman, chairman of NeuroScientific Biopharmaceuticals (ASX:NSB) Learn more about your ad choices. Visit megaphone.fm/adchoices Thu, 04 Feb 2021 01:38:00 -0000 full 1 44 Stockhead This week Tim chats with Brian Leedman, chairman of NeuroScientific Biopharmaceuticals (ASX:NSB) Learn more about your ad choices. Visit megaphone.fm/adchoices This week Tim chats with Brian Leedman, chairman of NeuroScientific Biopharmaceuticals (ASX:NSB)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1656 no Neuren is cashed up, confident and charging into a phase 3 trial This week Tim chats with Jon Pilcher, Chief Executive Officer at Neuren Pharmaceuticals (ASX:NEU) Learn more about your ad choices. Visit megaphone.fm/adchoices Thu, 26 Nov 2020 01:02:00 -0000 full 1 43 Stockhead This week Tim chats with Jon Pilcher, Chief Executive Officer at Neuren Pharmaceuticals (ASX:NEU) Learn more about your ad choices. Visit megaphone.fm/adchoices This week Tim chats with Jon Pilcher, Chief Executive Officer at Neuren Pharmaceuticals (ASX:NEU)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1518 The ASX's top performing 2019 IPO, Osteopore, discusses next steps, expansion plans and new markets Tim chats with Osteopore (ASX:OSX) executive director Geoff Pocock. Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 10 Nov 2020 05:25:00 -0000 full 1 42 Stockhead Tim chats with Osteopore (ASX:OSX) executive director Geoff Pocock. Learn more about your ad choices. Visit megaphone.fm/adchoices Tim chats with Osteopore (ASX:OSX) executive director Geoff Pocock.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1429 no Investors eye AdAlta's fibrosis fighting i-body platform Tim chats with Tim Oldham, CEO and Managing Director of AdAlta Limited (ASX:1AD). Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 10 Nov 2020 01:48:00 -0000 full 1 41 Stockhead Tim chats with Tim Oldham, CEO and Managing Director of AdAlta Limited (ASX:1AD). Learn more about your ad choices. Visit megaphone.fm/adchoices Tim chats with Tim Oldham, CEO and Managing Director of AdAlta Limited (ASX:1AD).

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1363 Investors smell success in Rhinomed's flu and coronavirus nasal swab technology https://stockhead.com.au/health/health-kick-podcast-investors-smell-success-in-rhinomeds-flu-and-coronavirus-nasal-swab-technology/ In this episode Tim chats with Michael Johnson, CEO & Executive Director of Rhinomed (ASX:RNO). Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 20 Oct 2020 06:03:00 -0000 full 1 40 Stockhead In this episode Tim chats with Michael Johnson, CEO & Executive Director of Rhinomed (ASX:RNO). Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats with Michael Johnson, CEO & Executive Director of Rhinomed (ASX:RNO).

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1584 no This biopharma company may be the world’s only exosome-based player https://stockhead.com.au/health/health-kick-podcast-this-biopharma-company-may-be-the-worlds-only-exosome-based-player/ In this episode Tim chats with Dr Chris Baldwin, Chief Commercial Officer of Exopharm (ASX:EX1) Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 14 Oct 2020 02:46:00 -0000 full 1 39 Stockhead In this episode Tim chats with Dr Chris Baldwin, Chief Commercial Officer of Exopharm (ASX:EX1) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats with Dr Chris Baldwin, Chief Commercial Officer of Exopharm (ASX:EX1)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1641 no Investor confidence is sky-high in Apiam's diversified pet and livestock veterinarian offering https://stockhead.com.au/health/health-kick-podcast-investors-love-apiams-diversified-pet-and-livestock-vet-offering/ Tim chats with Dr Chris Richards, Managing Director at Apiam Animal Health (ASX:AHX) Learn more about your ad choices. Visit megaphone.fm/adchoices Fri, 18 Sep 2020 05:05:00 -0000 full 1 38 Stockhead Tim chats with Dr Chris Richards, Managing Director at Apiam Animal Health (ASX:AHX) Learn more about your ad choices. Visit megaphone.fm/adchoices Tim chats with Dr Chris Richards, Managing Director at Apiam Animal Health (ASX:AHX)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1428 no PainChek's AI-backed pain assessment technology is a game-changer for treating infants and the elderly https://stockhead.com.au/health/health-kick-podcast-paincheks-ai-backed-pain-assessment-tech-a-game-changer-for-treating-infants-and-the-elderly/ This week Tim chats with Philip Daffas, CEO & Managing Director at PainChek (ASX:PCK) Learn more about your ad choices. Visit megaphone.fm/adchoices Fri, 18 Sep 2020 03:40:00 -0000 full 1 37 Stockhead This week Tim chats with Philip Daffas, CEO & Managing Director at PainChek (ASX:PCK) Learn more about your ad choices. Visit megaphone.fm/adchoices This week Tim chats with Philip Daffas, CEO & Managing Director at PainChek (ASX:PCK)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1432 no Investors still high on Incannex's cannabinoid pivot and COVID-19 treatment news https://stockhead.com.au/health/health-kick-investors-still-high-on-incannex-cannabinoid-pivot-and-covid-19-treatment-news/ This week Tim chats with Dr Sud Agarwal, Chief Medical Officer at Incannex Healthcare (ASX: IHL) Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 15 Sep 2020 07:08:00 -0000 full 1 36 Stockhead This week Tim chats with Dr Sud Agarwal, Chief Medical Officer at Incannex Healthcare (ASX: IHL) Learn more about your ad choices. Visit megaphone.fm/adchoices This week Tim chats with Dr Sud Agarwal, Chief Medical Officer at Incannex Healthcare (ASX: IHL)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1510 no Starpharma goes from strength to strength following news of progress on COVID-19 nasal spray https://stockhead.com.au/health/health-kick-podcast-starpharma-goes-from-strength-to-strength-following-news-of-progress-on-covid-19-nasal-spray/ This week Tim chats with Dr Jackie Fairley, CEO of Starpharma Holdings (ASX:SPL) Learn more about your ad choices. Visit megaphone.fm/adchoices Mon, 31 Aug 2020 06:22:00 -0000 full 1 35 Stockhead This week Tim chats with Dr Jackie Fairley, CEO of Starpharma Holdings (ASX:SPL) Learn more about your ad choices. Visit megaphone.fm/adchoices This week Tim chats with Dr Jackie Fairley, CEO of Starpharma Holdings (ASX:SPL)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1140 no Cannpal has first mover advantage in the $67bn "hidden gem" animal health market https://stockhead.com.au/health/health-kick-podcast-cannpal-has-first-mover-advantage-in-the-67bn-hidden-gem-animal-health-market/ This week Tim chats with Layton Mills, managing director of Cannpal Animal Therapeutics (ASX:CP1). Learn more about your ad choices. Visit megaphone.fm/adchoices Fri, 21 Aug 2020 06:02:00 -0000 full 1 34 Stockhead This week Tim chats with Layton Mills, managing director of Cannpal Animal Therapeutics (ASX:CP1). Learn more about your ad choices. Visit megaphone.fm/adchoices This week Tim chats with Layton Mills, managing director of Cannpal Animal Therapeutics (ASX:CP1).

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1445 no Chemo's diminishing role, the 'personalised' approach to cancer treatment and PTX's CAR-T innovations https://stockhead.com.au/health/health-kick-podcast-chemos-diminishing-role-the-personalised-approach-to-cancer-treatment-and-ptxs-car-t-innovations/ This week Tim chats with Steven Yatomi-Clarke, CEO and Managing Director of Prescient Therapeutics (ASX:PTX) Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 18 Aug 2020 07:40:00 -0000 full 1 33 Stockhead This week Tim chats with Steven Yatomi-Clarke, CEO and Managing Director of Prescient Therapeutics (ASX:PTX) Learn more about your ad choices. Visit megaphone.fm/adchoices This week Tim chats with Steven Yatomi-Clarke, CEO and Managing Director of Prescient Therapeutics (ASX:PTX)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1541 no Zelira's cannabis-derived insomnia treatment has investors dreaming https://stockhead.com.au/health/health-kick-zeliras-cannabis-derived-insomnia-treatment-has-investors-dreaming/ Tim chats with Dr Richard Hopkins, Managing Director of Zelira Therapeutics (ASX:ZLD) Learn more about your ad choices. Visit megaphone.fm/adchoices Thu, 13 Aug 2020 02:07:00 -0000 full 1 32 Stockhead Tim chats with Dr Richard Hopkins, Managing Director of Zelira Therapeutics (ASX:ZLD) Learn more about your ad choices. Visit megaphone.fm/adchoices Tim chats with Dr Richard Hopkins, Managing Director of Zelira Therapeutics (ASX:ZLD)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1378 no Botanix is using synthetic cannabinoids to treat acne and other skin conditions https://stockhead.com.au/health/health-kick-podcast-botanix-is-using-synthetic-cannabinoids-to-treat-acne-and-other-skin-conditions/ Tim chats with Matt Callahan, Executive Director of Botanix Pharmaceuticals (ASX: BOT) Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 29 Jul 2020 00:39:00 -0000 full 1 31 Stockhead Tim chats with Matt Callahan, Executive Director of Botanix Pharmaceuticals (ASX: BOT) Learn more about your ad choices. Visit megaphone.fm/adchoices Tim chats with Matt Callahan, Executive Director of Botanix Pharmaceuticals (ASX: BOT)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1476 no Pancreatic cancer treater OncoSil continues impressive bounce-back https://stockhead.com.au/health/health-kick-pancreatic-cancer-treater-oncosil-continues-impressive-bounce-back/ In this episode Tim chats with Daniel Kenny, Chief Executive Officer at OncoSil Medical (ASX: OSL). Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 14 Jul 2020 04:17:00 -0000 full 1 30 Stockhead In this episode Tim chats with Daniel Kenny, Chief Executive Officer at OncoSil Medical (ASX: OSL). Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats with Daniel Kenny, Chief Executive Officer at OncoSil Medical (ASX: OSL).

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1479 no This drug developer is up 200 percent after being included in a COVID-19 related trial https://stockhead.com.au/health/health-kick-this-drug-developer-is-up-200pc-following-inclusion-in-a-covid-19-related-trial/ Dr Nina Webster, Managing Director and CEO of Dimerix (ASX:DXB) Learn more about your ad choices. Visit megaphone.fm/adchoices Mon, 15 Jun 2020 04:45:00 -0000 full 1 29 Stockhead Dr Nina Webster, Managing Director and CEO of Dimerix (ASX:DXB) Learn more about your ad choices. Visit megaphone.fm/adchoices Dr Nina Webster, Managing Director and CEO of Dimerix (ASX:DXB)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1213 no VTI has a clear vision for the future of contact lenses https://stockhead.com.au/health/health-kick-vti-has-a-clear-vision-for-the-future-of-contact-lenses/ In this episode Tim chats with Dr Stephen Snowdy, CEO from Visioneering Technologies (ASX: VTI) Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 09 Jun 2020 07:07:00 -0000 full 1 28 Stockhead In this episode Tim chats with Dr Stephen Snowdy, CEO from Visioneering Technologies (ASX: VTI) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats with Dr Stephen Snowdy, CEO from Visioneering Technologies (ASX: VTI)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1668 no Cynata's stem cell therapy could be a game changer for COVID-19 patients https://stockhead.com.au/health/health-kick-cynatas-stem-cell-therapy-could-be-a-game-changer-for-covid-19-patients/ Tim chat's with Dr Ross Macdonald, CEO of Cynata Therapeutics (ASX:CYP). Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 03 Jun 2020 05:05:00 -0000 full 1 27 Stockhead Tim chat's with Dr Ross Macdonald, CEO of Cynata Therapeutics (ASX:CYP). Learn more about your ad choices. Visit megaphone.fm/adchoices Tim chat's with Dr Ross Macdonald, CEO of Cynata Therapeutics (ASX:CYP).

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1313 no Accurately measuring cognition offers massive upside to clinicians and drug makers, CGS is leading the charge https://stockhead.com.au/health/health-kick-podcast-accurately-measuring-cognition-offers-massive-upside-to-clinicians-and-drug-makers-cgs-has-the-tech/ In this episode Tim chats with Brad O'Connor, Managing Director and CEO of CogState (ASX: CGS) Learn more about your ad choices. Visit megaphone.fm/adchoices Mon, 18 May 2020 06:06:00 -0000 full 1 26 Stockhead In this episode Tim chats with Brad O'Connor, Managing Director and CEO of CogState (ASX: CGS) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats with Brad O'Connor, Managing Director and CEO of CogState (ASX: CGS)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1641 no Can Aussie drug makers survive COVID-19? And what can we learn from Chemgenex success? https://stockhead.com.au/health/health-kick-podcast-can-listed-aussie-drug-makers-survive-covid-19/ In this episode Tim chats with James Campbell, CEO of Patrys (ASX: PAB) Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 06 May 2020 04:49:00 -0000 full 1 25 Stockhead In this episode Tim chats with James Campbell, CEO of Patrys (ASX: PAB) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats with James Campbell, CEO of Patrys (ASX: PAB)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1323 no Chronic kidney disease is a worldwide health crisis, ASX-listed DXB driving improved treatment https://stockhead.com.au/health/health-kick-podcast-chronic-kidney-disease-is-a-worldwide-health-crisis-asx-listed-dxb-is-driving-improved-treatment/ In this episode Tim chats with Nina Webster, CEO and managing director of Dimerix (ASX: DXB) Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 15 Apr 2020 00:07:00 -0000 full 1 24 Stockhead In this episode Tim chats with Nina Webster, CEO and managing director of Dimerix (ASX: DXB) Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats with Nina Webster, CEO and managing director of Dimerix (ASX: DXB)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1257 Increasing athletic performance and fighting sleep apnea with a simple nose clip https://stockhead.com.au/health/health-kick-podcast-increasing-athletic-performance-and-fighting-sleep-apnea-with-a-simple-nose-clip/ In this episode Tim chats with Michael Johnson, Managing Director and CEO of Rhinomed (ASX:RNO). Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 31 Mar 2020 00:28:00 -0000 full 1 23 Stockhead In this episode Tim chats with Michael Johnson, Managing Director and CEO of Rhinomed (ASX:RNO). Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats with Michael Johnson, Managing Director and CEO of Rhinomed (ASX:RNO).

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1453 Understanding immunotherapy, why the market dried up and Immutep's profitable potential https://stockhead.com.au/health/health-kick-podcast-understanding-immunotherapy-why-the-drug-market-dried-up-and-immuteps-profitable-potential/ In this episode Tim chats with Marc Voigt, Executive Director and CEO of Immutep (ASX:IMM). Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 17 Mar 2020 22:34:00 -0000 full 1 22 Stockhead In this episode Tim chats with Marc Voigt, Executive Director and CEO of Immutep (ASX:IMM). Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats with Marc Voigt, Executive Director and CEO of Immutep (ASX:IMM).

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1246 no Memphasys is using electrical forces on sperm to get better IVF results https://stockhead.com.au/health/health-kick-podcast-memphasys-is-electro-shocking-sperm-into-better-ivf-performance/ In this episode Tim chats with Alison Coutts, Executive Chairman of Memphasys (ASX:MEM). Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 10 Mar 2020 04:19:00 -0000 full 1 21 Stockhead In this episode Tim chats with Alison Coutts, Executive Chairman of Memphasys (ASX:MEM). Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats with Alison Coutts, Executive Chairman of Memphasys (ASX:MEM).

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1243 no Understanding the strategy and upside behind global cannabis investment company MMJ https://stockhead.com.au/food-agriculture/health-kick-podcast-the-strategy-and-upside-behind-global-cannabis-investment-company-mmj/ In this episode Tim chats with Michael Curtis, director at MMJ Group Holdings (ASX:MMJ) and CEO of Embark Health. Learn more about your ad choices. Visit megaphone.fm/adchoices Thu, 05 Mar 2020 05:12:00 -0000 full 1 20 Stockhead In this episode Tim chats with Michael Curtis, director at MMJ Group Holdings (ASX:MMJ) and CEO of Embark Health. Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats with Michael Curtis, director at MMJ Group Holdings (ASX:MMJ) and CEO of Embark Health.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1211 no Could oral sprays replace pills as a better means of drug delivery for some medicines? https://stockhead.com.au/health/health-kick-podcast-could-oral-sprays-replace-pills-as-a-better-means-of-drug-delivery/ In this episode Tim chats with Dr Michael Baker, CEO of Suda Pharmaceuticals (ASX:SUD). Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 03 Mar 2020 05:52:00 -0000 full 1 19 Stockhead In this episode Tim chats with Dr Michael Baker, CEO of Suda Pharmaceuticals (ASX:SUD). Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats with Dr Michael Baker, CEO of Suda Pharmaceuticals (ASX:SUD).

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1251 no The ASX's only medicinal honey player, the market post bush fires and what Amazon offers producers https://stockhead.com.au/food-agriculture/health-kick-podcast-the-asxs-only-medicinal-honey-player-and-the-advantage-of-amazon-aided-us-exposure/ In this episode Tim chats with Bill Fry, Managing Director of Eve Investments (ASX:EVE). Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 26 Feb 2020 04:52:00 -0000 full 1 18 Stockhead In this episode Tim chats with Bill Fry, Managing Director of Eve Investments (ASX:EVE). Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats with Bill Fry, Managing Director of Eve Investments (ASX:EVE).

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1357 no Skyrocketing prescription drug prices, Trump's plan for the drug market and NOX's impressive pipeline https://stockhead.com.au/health/health-kick-podcast-skyrocketing-prescription-prices-and-trumps-plan-for-the-drug-market/ Tim speaks with Noxopharm (ASX:NOX) Executive Chairman and CEO, Graham Kelly Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 19 Feb 2020 02:35:00 -0000 full 1 17 Stockhead Tim speaks with Noxopharm (ASX:NOX) Executive Chairman and CEO, Graham Kelly Learn more about your ad choices. Visit megaphone.fm/adchoices Tim speaks with Noxopharm (ASX:NOX) Executive Chairman and CEO, Graham Kelly

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1397 no Coronavirus, HIV and Hepatitis are in the sights of Aussie biotech Biotron In this episode Tim chats with Dr Michelle Miller, chief executive officer and managing director of Biotron Limited (ASX:BIT). Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 12 Feb 2020 03:58:00 -0000 full 1 16 Stockhead In this episode Tim chats with Dr Michelle Miller, chief executive officer and managing director of Biotron Limited (ASX:BIT). Learn more about your ad choices. Visit megaphone.fm/adchoices In this episode Tim chats with Dr Michelle Miller, chief executive officer and managing director of Biotron Limited (ASX:BIT).

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1447 Novel gene targeting therapies, protein disruptors and why ANP's recent trial success have investors buzzing Tim speaks with Antisense (ASX:ANP) managing director and CEO, Mark Diamond Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 05 Feb 2020 04:01:00 -0000 full 1 15 Stockhead Tim speaks with Antisense (ASX:ANP) managing director and CEO, Mark Diamond Learn more about your ad choices. Visit megaphone.fm/adchoices Tim speaks with Antisense (ASX:ANP) managing director and CEO, Mark Diamond

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1503 Learning from the Swine flu pandemic, the market potential of exosome therapeutics and jumping ASX life-sciences hurdles Tim chats with Carl Stubbings, CEO and MD of Sienna Cancer Diagnostics (ASX:SDX). Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 29 Jan 2020 07:33:00 -0000 full 1 14 Stockhead Tim chats with Carl Stubbings, CEO and MD of Sienna Cancer Diagnostics (ASX:SDX). Learn more about your ad choices. Visit megaphone.fm/adchoices Tim chats with Carl Stubbings, CEO and MD of Sienna Cancer Diagnostics (ASX:SDX).

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1252 no Commercialising orphan drugs, the need for better biotech regulation the ASX's lifestyle play problems Tim chats with Race Oncology (ASX:RCE) CEO Peter Molloy and executive director and CSO Daniel Tillett. Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 18 Dec 2019 07:00:00 -0000 full 1 13 Stockhead Tim chats with Race Oncology (ASX:RCE) CEO Peter Molloy and executive director and CSO Daniel Tillett. Learn more about your ad choices. Visit megaphone.fm/adchoices Tim chats with Race Oncology (ASX:RCE) CEO Peter Molloy and executive director and CSO Daniel Tillett.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1560 The science behind 2019's hottest IPO and the company's next steps Tim chats with Osteopore (ASX:OSX) executive director Geoff Pocock Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 11 Dec 2019 03:41:00 -0000 full 1 12 Stockhead Tim chats with Osteopore (ASX:OSX) executive director Geoff Pocock Learn more about your ad choices. Visit megaphone.fm/adchoices Tim chats with Osteopore (ASX:OSX) executive director Geoff Pocock

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1267 no Investing in repurposed drugs, combatting intracranial pressure and why Invex caught NASA's eye Tim speaks with Invex founder and CEO Alex Sinclair, as well as the company's chairman Dr Jason Loveridge. Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 04 Dec 2019 05:55:00 -0000 full 1 11 Stockhead Tim speaks with Invex founder and CEO Alex Sinclair, as well as the company's chairman Dr Jason Loveridge. Learn more about your ad choices. Visit megaphone.fm/adchoices Tim speaks with Invex founder and CEO Alex Sinclair, as well as the company's chairman Dr Jason Loveridge.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1198 What's holding back better breast cancer detection? And how is Volpara's tech changing the game? Tim chats with executive director and CEO of Volpara Health Technologies Ralph Highnam. Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 27 Nov 2019 06:19:00 -0000 full 1 10 Stockhead Tim chats with executive director and CEO of Volpara Health Technologies Ralph Highnam. Learn more about your ad choices. Visit megaphone.fm/adchoices Tim chats with executive director and CEO of Volpara Health Technologies Ralph Highnam.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1305 no Developing drugs, fighting fibrosis and squeezing squishometers Tim chats with CEO and MD Dimerix Nina Webster, and CEO of Pharmaxis Gary Phillips. Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 20 Nov 2019 05:58:00 -0000 full 1 9 Stockhead Tim chats with CEO and MD Dimerix Nina Webster, and CEO of Pharmaxis Gary Phillips. Learn more about your ad choices. Visit megaphone.fm/adchoices Tim chats with CEO and MD Dimerix Nina Webster, and CEO of Pharmaxis Gary Phillips.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1424 no How Aussie health stocks are performing internationally and Prescient's cancer-blocking innovation Tim chats with Steven Yatomi-Clarke, CEO and managing director of Prescient Therapeutics (ASX:PTX). Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 13 Nov 2019 04:08:00 -0000 full 1 8 Stockhead Tim chats with Steven Yatomi-Clarke, CEO and managing director of Prescient Therapeutics (ASX:PTX). Learn more about your ad choices. Visit megaphone.fm/adchoices Tim chats with Steven Yatomi-Clarke, CEO and managing director of Prescient Therapeutics (ASX:PTX).

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1116 no The growth of musculoskeletal disorders, new markets created by ageing populations and OCC's Avatar moment Tim chats all things regenerative medicine with Paul Anderson, founder and CEO of Orthocell (ASX:OCC). Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 06 Nov 2019 06:10:00 -0000 full 1 7 Stockhead Tim chats all things regenerative medicine with Paul Anderson, founder and CEO of Orthocell (ASX:OCC). Learn more about your ad choices. Visit megaphone.fm/adchoices Tim chats all things regenerative medicine with Paul Anderson, founder and CEO of Orthocell (ASX:OCC).

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1414 no The future of X-ray, a new way to image the body and challenging clinical practice. Tim chats with Michael Harsh, non-executive director at Imagion Biosystens (ASX:IBX). Learn more about your ad choices. Visit megaphone.fm/adchoices Tue, 29 Oct 2019 01:56:00 -0000 full 1 6 Stockhead Tim chats with Michael Harsh, non-executive director at Imagion Biosystens (ASX:IBX). Learn more about your ad choices. Visit megaphone.fm/adchoices Tim chats with Michael Harsh, non-executive director at Imagion Biosystens (ASX:IBX).

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1247 no The death of the doctor's clipboard, how Alcidion’s infomatics saves lives and why it's best to bide time on a US entrance. Tim chat's with Alcidion’s Group Managing Director, Kate Quirke. Learn more about your ad choices. Visit megaphone.fm/adchoices Thu, 24 Oct 2019 06:26:00 -0000 full 1 5 Stockhead Tim chat's with Alcidion’s Group Managing Director, Kate Quirke. Learn more about your ad choices. Visit megaphone.fm/adchoices Tim chat's with Alcidion’s Group Managing Director, Kate Quirke.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1319 no Anatara Lifesciences: Standing out in the gut health market, solving scours in livestock and the future of antibiotics in the food chain. Tim chats with Steven Lydeamore, CEO of Anatara Lifesciences (ASX:ANR). Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 16 Oct 2019 06:36:00 -0000 full 1 4 Stockhead Tim chats with Steven Lydeamore, CEO of Anatara Lifesciences (ASX:ANR). Learn more about your ad choices. Visit megaphone.fm/adchoices Tim chats with Steven Lydeamore, CEO of Anatara Lifesciences (ASX:ANR).

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1356 no Kazia Therapeutics: Beating glioblastoma, crossing the blood-brain barrier and the joys of receiving a gong from Jacinda Ardern. Tim chats with Dr James Garner, CEO & Executive Director of Kazia Therapeutics (ASX:KZA). Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 09 Oct 2019 06:07:00 -0000 full 1 3 Stockhead Tim chats with Dr James Garner, CEO & Executive Director of Kazia Therapeutics (ASX:KZA). Learn more about your ad choices. Visit megaphone.fm/adchoices Tim chats with Dr James Garner, CEO & Executive Director of Kazia Therapeutics (ASX:KZA).

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1240 no BioScience Managers: Folding and holding in the biotech game, the perils of an early IPO and the slow burn of the Aussie health sector. Tim chats with Matt McNamara, CIO of international healthcare investment firm BioScience Managers. Learn more about your ad choices. Visit megaphone.fm/adchoices Mon, 30 Sep 2019 06:51:00 -0000 full 1 2 Stockhead Tim chats with Matt McNamara, CIO of international healthcare investment firm BioScience Managers. Learn more about your ad choices. Visit megaphone.fm/adchoices Tim chats with Matt McNamara, CIO of international healthcare investment firm BioScience Managers.

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1607 no Oventus Medical: The war on snoring, spousal homicide and the mouth guard that caught Alan Moss' eye. Tim chats with Chris Hart, founder, managing director and CEO of Oventus Medical (ASX:OVN) Learn more about your ad choices. Visit megaphone.fm/adchoices Wed, 25 Sep 2019 08:28:00 -0000 full 1 1 Stockhead Tim chats with Chris Hart, founder, managing director and CEO of Oventus Medical (ASX:OVN) Learn more about your ad choices. Visit megaphone.fm/adchoices Tim chats with Chris Hart, founder, managing director and CEO of Oventus Medical (ASX:OVN)

Learn more about your ad choices. Visit megaphone.fm/adchoices

]]> 1171 no